Cui; Jingrong

Patent Applications and Registrations

Patent applications and USPTO patent grants for Cui; Jingrong.The latest application filed is for "urea peptoid boric acid compound, pharmaceutical composition thereof, preparation method therefor, and uses thereof".

Company Profile

1.14.16

Cui; Jingrong - Beijing CN
Cui; Jingrong - San Diego CA
Cui; Jingrong - Foster City CA
Cui; Jingrong - Albany CA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Urea peptoid boric acid compound, pharmaceutical composition thereof, preparation method therefor, and uses thereof Grant 10,494,384 - Li , et al. De	2019-12-03
Urea Peptoid Boric Acid Compound, Pharmaceutical Composition Thereof, Preparation Method Therefor, And Uses Thereof App 20180298036 - Li; Runtao ; et al.	2018-10-18
Tripeptide boronic acid or boronic ester, preparative method and use thereof Grant 9,421,237 - Li , et al. August 23, 2	2016-08-23
Heteroaryl (alkyl) Dithiocarbamate Compounds, Preparation Methods And Uses Thereof App 20130136794 - Li; Runtao ; et al.	2013-05-30
Tripetide Boronic Acid Or Boronic Ester, Preparative Method And Use Thereof App 20120135921 - Li; Runtao ; et al.	2012-05-31
Arylmethyl triazolo- and imidazopyrazines as c-Met inhibitors Grant 7,250,417 - Cui , et al. July 31, 2	2007-07-31
Triazolotriazine compounds and uses thereof Grant 7,122,548 - Zhang , et al. October 17, 2	2006-10-17
Geometrically restricted 3-cyclopentylidene-1,3-dihydroindol-2-ones as potent protein tyrosine kinase inhibitors Grant 7,105,562 - Zhang , et al. September 12, 2	2006-09-12
4-heteroaryl-3-heteroarylidenyl-2-indolinones and their use as protein kinase inhibitors Grant 7,053,086 - Tang , et al. May 30, 2	2006-05-30
Tetracyclic compounds as c-Met inhibitors Grant 7,037,909 - Vojkovsky , et al. May 2, 2	2006-05-02
Indolinone hydrazides as c-Met inhibitors App 20060009493 - Koenig; Marcel ; et al.	2006-01-12
4-substituted 7-AZA-indolin-2-ones and their use as protein kinase inhibitors Grant 6,908,930 - Liang , et al. June 21, 2	2005-06-21
Arylmethyl triazolo-and imidazopyrazines as c-Met inhibitors App 20050107391 - Cui, Jingrong ; et al.	2005-05-19
Triazolotriazine compounds and uses thereof App 20050075340 - Zhang, Fang-Jie ; et al.	2005-04-07
4-aryl substituted indolinones Grant 6,861,418 - Cui , et al. March 1, 2	2005-03-01
Geometrically restricted 3-cyclopentylidene-1,3-dihydroindol-2-ones as potent protein tyrosine kinase inhibitors App 20050038066 - Zhang, Fang-Jie ; et al.	2005-02-17
Tetracyclic compounds as c-Met inhibitors App 20050014755 - Vojkovsky, Tomas ; et al.	2005-01-20
4-Aryl substituted indolinones App 20040157909 - Cui, Jingrong ; et al.	2004-08-12
4-heteroaryl-3-heteroarylidenyl-2-indolinones and their use as protein kinase inhibitors App 20040097497 - Tang, Peng Cho ; et al.	2004-05-20
4-Substituted 7-aza-indolin-2-ones and their use as protein kinase inhibitors App 20040053924 - Liang, Congxin ; et al.	2004-03-18
4-aryl substituted indolinones Grant 6,677,368 - Cui , et al. January 13, 2	2004-01-13
4-heteroaryl-3-heteroarylidenyl-2-indolinones and their use as protein kinase inhibitors Grant 6,635,640 - Tang , et al. October 21, 2	2003-10-21
4-substituted 7-aza-indolin-2-ones and their use as protein kinase inhibitors Grant 6,610,688 - Liang , et al. August 26, 2	2003-08-26
Piperazine mono(dithio)carbamate ester compounds and analogs thereof: preparation method and uses thereof App 20030149021 - Li, Runtao ; et al.	2003-08-07
5-aralkysufonyl-3-(pyrrol-2-ylmethylidene)-2-indolinone derivatives as kinase inhibitors Grant 6,599,902 - Cui , et al. July 29, 2	2003-07-29
5-aralkysufonyl-3-(pyrrol-2-ylmethylidene)-2-indolinone Derivatives As Kinase Inhibitors App 20030125370 - Cui, Jingrong ; et al.	2003-07-03
4-Heteroaryl-3-heteroarylidenyl-2-indolinones and their use as protein kinase inhibitors App 20020187978 - Tang, Peng Cho ; et al.	2002-12-12
4-substituted 7-aza-indolin-2-ones and their use as protein kinase inhibitors App 20020183319 - Liang, Congxin ; et al.	2002-12-05

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.